Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NeuroBlate Fusion-S Software V3.17

K-Number: K222983 · 2023-03-15

Decision Date2023-03-15
Product CodeGEX
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

NeuroBlate Fusion-S Software V3.17 is a medical device manufactured by Monteris Medical,. It received FDA 510(k) clearance on 2023-03-15 under approval number K222983. The device is classified under product code GEX. It was reviewed by the SU advisory panel. Product code GEX falls under the category of Gastroenterology, which includes gastrointestinal diagnostic and therapeutic devices. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NeuroBlate Fusion-S Software V3.17?

NeuroBlate Fusion-S Software V3.17 is a medical device that received FDA 510(k) clearance on 2023-03-15. It is manufactured by Monteris Medical,. The 510(k) number is K222983.

When was NeuroBlate Fusion-S Software V3.17 approved by the FDA?

NeuroBlate Fusion-S Software V3.17 received FDA 510(k) clearance on 2023-03-15, under approval number K222983.

What company makes NeuroBlate Fusion-S Software V3.17?

NeuroBlate Fusion-S Software V3.17 is manufactured by Monteris Medical,.

What is the FDA product code for NeuroBlate Fusion-S Software V3.17?

The FDA product code for NeuroBlate Fusion-S Software V3.17 is GEX. This falls under the Gastroenterology category.

Other Devices by Monteris Medical,

View all 8 devices →

Related Devices (Code: GEX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.